The table below summarizes the most recent CBIO insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why CBIO insider buys are important for investors to follow.

Date	Insider	Price	Amount
8-9-2022 Insider Buy	Grant E. Blouse Chief Scientific Officer	$0.47 CAGR »	$1,527.50 3,250 shares
8-9-2022 Insider Buy	Seline E. Miller SVP Finance; Interim CFO & PAO	$0.47 CAGR »	$1,527.50 3,250 shares
8-9-2022 Insider Buy	Nassim Usman President & CEO	$0.47 CAGR »	$1,527.50 3,250 shares
2-9-2022 Insider Buy	Grant E. Blouse Chief Scientific Officer	$0.46 CAGR »	$1,495.00 3,250 shares
2-9-2022 Insider Buy	Seline E. Miller SVP Finance; Interim CFO & PAO	$0.46 CAGR »	$1,495.00 3,250 shares
2-9-2022 Insider Buy	Nassim Usman President & CEO	$0.46 CAGR »	$1,495.00 3,250 shares
8-9-2021 Insider Buy	Nassim Usman President & CEO	$3.62 CAGR »	$3,138.54 867 shares
8-9-2021 Insider Buy	Grant E. Blouse Chief Scientific Officer	$3.62 CAGR »	$4,210.06 1,163 shares
8-9-2021 Insider Buy	Howard Levy Chief Medical Officer	$3.62 CAGR »	$2,313.18 639 shares
3-13-2020 Insider Buy	Veronica Cai Controller	$4.11 CAGR »	$8,220.00 2,000 shares
3-13-2020 Insider Buy	John P. Richard Director	$3.98 CAGR »	$9,950.00 2,500 shares
3-13-2020 Insider Buy	Nassim Usman President & CEO	$3.91 CAGR »	$15,647.20 4,000 shares
2-25-2020 Insider Buy	Geoffrey M.D. Ling Director	$6.23 CAGR »	$18,691.50 3,000 shares
5-24-2019 Insider Buy	John P. Richard Director	$8.03 CAGR »	$8,030.00 1,000 shares
12-17-2015 Insider Buy	Stephen A. Hill Director	$2.03 CAGR »	$10,150.00 5,000 shares
12-17-2015 Insider Buy	Fletcher Payne Chief Financial Officer	$2.00 CAGR »	$20,000.00 10,000 shares

Also See: Institutional Holders of CBIO
Also See: SEC filings

Below we present the annualized performance delivered by CBIO stock since 8-9-2022 (the date of the most recent insider purchase). The performance of the investment from the time CBIO insider buying occurred is the ultimate test of whether insiders were right about CBIO being a good buy.

Growth of $10,000.00 With Dividends Reinvested
Start date:	08/10/2022
End date:	10/30/2023
Start price/share:	$1.85
End price/share:	$0.51
Starting shares:	5,405.41
Ending shares:	40,124.74
Dividends reinvested/share:	$1.67
Total return:	104.64%
Average Annual Total Return:	79.68%
Starting investment:	$10,000.00
Ending investment:	$20,463.40
Years:	1.22

Growth of $10,000.00 Without Dividends Reinvested
Start date:	08/10/2022
End date:	10/30/2023
Start price/share:	$1.85
End price/share:	$0.51
Dividends collected/share:	$1.67
Total return:	17.84%
Average Annual Total Return:	14.38%
Starting investment:	$10,000.00
Ending investment:	$11,784.17
Years:	1.22

CBIO Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent CBIO insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding CBIO

CBIO — Current Quote

Quotes delayed 20 minutes

Free CBIO Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

CBIO — Performance

More Insider Buying

Other companies seeing insider buying close in time to when the CBIO Insider Buying occurred are:

MCRB Insider Buying
TCMD Insider Buying
CHRD Insider Buying
CNXA Insider Buying
PSN Insider Buying
LL Insider Buying
NVR Insider Buying
KKR Insider Buying
SI Insider Buying
PSTX Insider Buying

CBIO Insider Buying

CBIO Insider Buying | www.HoldingsChannel.com